Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: A double blind, controlled study

F. Francini-Pesenti, F. Brocadello, D. Beltramolli, M. Nardi, L. Caregaro

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Previous clinical studies have shown that oral administration of sugar cane policosanol (SCP) reduces plasma total cholesterol and low-density lipoprotein cholesterol levels. A double blind, randomized, placebo controlled trial was performed in hypercholesterolaemic, diet-resistant patients. Seventy patients meeting the selection criteria were enrolled. Each subject was treated with policosanol 10 mg/d in addition to a dietetic regimen for 8 weeks. At the start and at the end of the study body weight, body mass index (BMI), total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (TG) plasma levels were measured. Thirty-three subjects in the policosanol and Thirty-one subjects in the control group completed the study. During the study body mass index, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides plasma levels did not change significantly within and between groups. In conclusion, sugar cane policosanol at a dose of 10 mg/d showed no lipid lowering effects in subjects with primitive, diet-resistant hypercholesterolaemia.

Original languageEnglish
Pages (from-to)61-65
Number of pages5
JournalComplementary Therapies in Medicine
Volume16
Issue number2
DOIs
Publication statusPublished - Apr 2008

Fingerprint

policosanol
Canes
Hypercholesterolemia
Double-Blind Method
Cholesterol
LDL Cholesterol
Diet
Patient Selection
HDL Cholesterol
Body Mass Index
Dietetics
Oral Administration
Randomized Controlled Trials
Placebos
Body Weight
Lipids
Control Groups

Keywords

  • Hypercholesterolaemia
  • Long-chain aliphatic primary alcohols
  • Policosanol
  • Sugar cane wax

ASJC Scopus subject areas

  • Medicine(all)
  • Complementary and alternative medicine
  • Nursing(all)

Cite this

Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia : A double blind, controlled study. / Francini-Pesenti, F.; Brocadello, F.; Beltramolli, D.; Nardi, M.; Caregaro, L.

In: Complementary Therapies in Medicine, Vol. 16, No. 2, 04.2008, p. 61-65.

Research output: Contribution to journalArticle

@article{87f2658872be4b7c8096af739d63bb04,
title = "Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: A double blind, controlled study",
abstract = "Previous clinical studies have shown that oral administration of sugar cane policosanol (SCP) reduces plasma total cholesterol and low-density lipoprotein cholesterol levels. A double blind, randomized, placebo controlled trial was performed in hypercholesterolaemic, diet-resistant patients. Seventy patients meeting the selection criteria were enrolled. Each subject was treated with policosanol 10 mg/d in addition to a dietetic regimen for 8 weeks. At the start and at the end of the study body weight, body mass index (BMI), total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (TG) plasma levels were measured. Thirty-three subjects in the policosanol and Thirty-one subjects in the control group completed the study. During the study body mass index, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides plasma levels did not change significantly within and between groups. In conclusion, sugar cane policosanol at a dose of 10 mg/d showed no lipid lowering effects in subjects with primitive, diet-resistant hypercholesterolaemia.",
keywords = "Hypercholesterolaemia, Long-chain aliphatic primary alcohols, Policosanol, Sugar cane wax",
author = "F. Francini-Pesenti and F. Brocadello and D. Beltramolli and M. Nardi and L. Caregaro",
year = "2008",
month = "4",
doi = "10.1016/j.ctim.2007.08.003",
language = "English",
volume = "16",
pages = "61--65",
journal = "Complementary Therapies in Medicine",
issn = "0965-2299",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia

T2 - A double blind, controlled study

AU - Francini-Pesenti, F.

AU - Brocadello, F.

AU - Beltramolli, D.

AU - Nardi, M.

AU - Caregaro, L.

PY - 2008/4

Y1 - 2008/4

N2 - Previous clinical studies have shown that oral administration of sugar cane policosanol (SCP) reduces plasma total cholesterol and low-density lipoprotein cholesterol levels. A double blind, randomized, placebo controlled trial was performed in hypercholesterolaemic, diet-resistant patients. Seventy patients meeting the selection criteria were enrolled. Each subject was treated with policosanol 10 mg/d in addition to a dietetic regimen for 8 weeks. At the start and at the end of the study body weight, body mass index (BMI), total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (TG) plasma levels were measured. Thirty-three subjects in the policosanol and Thirty-one subjects in the control group completed the study. During the study body mass index, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides plasma levels did not change significantly within and between groups. In conclusion, sugar cane policosanol at a dose of 10 mg/d showed no lipid lowering effects in subjects with primitive, diet-resistant hypercholesterolaemia.

AB - Previous clinical studies have shown that oral administration of sugar cane policosanol (SCP) reduces plasma total cholesterol and low-density lipoprotein cholesterol levels. A double blind, randomized, placebo controlled trial was performed in hypercholesterolaemic, diet-resistant patients. Seventy patients meeting the selection criteria were enrolled. Each subject was treated with policosanol 10 mg/d in addition to a dietetic regimen for 8 weeks. At the start and at the end of the study body weight, body mass index (BMI), total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (TG) plasma levels were measured. Thirty-three subjects in the policosanol and Thirty-one subjects in the control group completed the study. During the study body mass index, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides plasma levels did not change significantly within and between groups. In conclusion, sugar cane policosanol at a dose of 10 mg/d showed no lipid lowering effects in subjects with primitive, diet-resistant hypercholesterolaemia.

KW - Hypercholesterolaemia

KW - Long-chain aliphatic primary alcohols

KW - Policosanol

KW - Sugar cane wax

UR - http://www.scopus.com/inward/record.url?scp=44349151865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349151865&partnerID=8YFLogxK

U2 - 10.1016/j.ctim.2007.08.003

DO - 10.1016/j.ctim.2007.08.003

M3 - Article

C2 - 18514906

AN - SCOPUS:44349151865

VL - 16

SP - 61

EP - 65

JO - Complementary Therapies in Medicine

JF - Complementary Therapies in Medicine

SN - 0965-2299

IS - 2

ER -